|
German Dementia Registry
RECRUITINGSponsored by RWTH Aachen University
Actively Recruiting
SponsorRWTH Aachen University
Started2022-05-16
Est. completion2099-12
Eligibility
Age18 Years+
Healthy vol.Accepted
View on ClinicalTrials.gov →
NCT07433010
Summary
The German Dementia Registry (DEMREG) is a large-scale national prospective biomarker-based study for cognitive impairment and dementia, providing an integrated clinical research platform for research studies.
Eligibility
Age: 18 Years+Healthy volunteers accepted
Inclusion Criteria: Inclusion Criteria for Patient: * Ability of the participant and/or his/her legally authorized representative (e.g., spouse or legal guardian), as appropriate and applicable, to understand the purpose and risks of the register and provide signed and dated informed consent and authorization to use protected health information (PHI) in accordance with national and local privacy regulations. * Participating patients must have a diagnosis of SCD, MCI or early dementia of different etiology (i.e. Alzheimer's Disease, Frontotemporal Dementia, Parkinson's Disease, Lewy-Body Dementia, Progressive Supranuclear Palsy, Corticobasal Degeneration, Normal Pressure Hydrocephalus, Major Depression; Vascular Dementia; TDP-43 associated limbic encephalopathy (LATE), Mixed Dementia AD + VaD, Prion-Associated Dementia) together with biomarkers such as cerebrospinal fluids (CSF) amyloid beta 1-42, amyloid beta 1-40, amyloid beta 1-42/amyloid beta 1-40 ratio, total tau and phosphorylated tau, amyloid or tau imaging. * At least 18 years of age. Inclusion Criteria for family member: * At least 18 years of age. * Patient was included in the registry * Family member is strongly involved to the patient's life according to the patient's statement * Ability of the participant, as appropriate and applicable, to understand the purpose and risks of the register Exclusion Criteria: Exclusion Criteria for Patient: * Unwilling to provide informed consent. * No available biomarkers such as cerebrospinal fluids (CSF) amyloid beta 1-42, amyloid beta 1-40, amyloid beta 1-42/amyloid beta 1-40 ratio, total tau and phosphorylated tau, amyloid or tau imaging. Exclusion Criteria for family member: * Unable or unwilling to provide informed consent.
Conditions2
Alzheimer's DiseaseDementia Disorder
Browse More Trials
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.
Actively Recruiting
SponsorRWTH Aachen University
Started2022-05-16
Est. completion2099-12
Eligibility
Age18 Years+
Healthy vol.Accepted
View on ClinicalTrials.gov →
NCT07433010